arrow
D

Diego Palumbo

azienda ospedaliera universitaria integrata verona
H指数:26
被引数:2,278

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study

PD-L1 ≥ 50% 非小细胞肺癌中cemiplimab单药或联合短程化疗的超进展:一项生物标志物指导的多中心国际II期试验—HYPERBOLIC研究

2026-09-010
PRE
Short-term versus long-course neoadjuvant chemotherapy for resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results from the second randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial

可切除和临界可切除胰腺导管腺癌的短期与长期新辅助化疗比较(PACT-21 CASSANDRA):一项随机、开放标签、2×2析因设计的III期试验第二次随机化分析结果

2026-09-010
OAAI
Prognostic models and predictors of recurrence in resectable colorectal liver metastases: A systematic review and meta-analysis

可切除结直肠癌肝转移的预后模型和复发预测因素:一项系统评价和荟萃分析

2026-09-010
PRE
RENAL FUNCTIONAL FOLLOWING ANGIOEMBOLIZATION AFTER PARTIAL NEPHRECTOMY

部分肾切除术后行血管栓塞术后的肾功能

2026-05-010
PRE
EUS-guided drainage of Post-Surgical versus Post-Pancreatitis collections (the RESPELL study): A prospective comparison of clinical presentations and therapeutic outcomes
2026-01-220
OAAI
Alternation of mri and eus in pancreatic cancer screening could increase detection of both pancreatic and extra-pancreatic findings

MRI与EUS在胰腺癌筛查中的交替使用可能提高对胰腺及胰腺外发现的检出率。

2025-10-310
PRE
Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma

一项关于术前化疗联合mFOLFIRINOX或PAXG方案治疗I-III期胰腺导管腺癌的随机III期试验结果

2025-10-310
PRE
Evaluation of external validity of the distal pancreatectomy fistula risk score (D-FRS) in a high-volume center

评价远端胰腺切除术瘘管风险评分(D-FRS)在外部有效性的研究:一项高容量中心的研究

2025-09-010
PRE
Correction: Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT

更正:放射性栓塞术治疗肝细胞癌:比较双期锥形束CT、对比增强CT(CECT)和99mTc-大颗粒聚合白蛋白-SPECT/CT在预测栓塞后90Y PET/CT最终分布容积和剂量学方面的应用

2025-06-230
OAAI
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness

解剖学可切除与生物学临界可切除胰腺癌定义:超越解剖标准和生物学侵袭性的边界界定

2025-05-201
OA
Predicting the need for step-up after EUS-guided drainage of peripancreatic fluid collections, including Quadrant-Necrosis-Infection score validation: a prospective cohort study

预测内镜超声引导下胰腺周围积液引流术后需要升级治疗的必要性,包括Quadrant-Necrosis-Infection评分验证:一项前瞻性队列研究

2025-01-200
PRE
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT

肝细胞癌的放射栓塞: 双相锥形束CT,对比增强CT (CECT) 和99mtc-大分子聚集白蛋白-SPECT/CT在预测栓塞后90Y PET/CT的最终分布体积和剂量学中的比较

2024-12-200
OAAI
Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus
2024-04-301
PRE